Most cited papers from Banner Health

Banner Health

What are the most cited papers from Banner Health?

The most cited paper from Banner Health is "Toward defining the preclinical stages of Alzheimer's disease: Recommendations from the National Institute on Aging‐Alzheimer's Association workgroups on diagnostic guidelines for Alzheimer's disease" (Reisa Anne Sperling et al., 2011), with 7,286 citations. Next come "Signet-Ring Cell Carcinoma of the Colon: A Case Report and Review of the Literature" (5,277) and "Transcatheter Aortic-Valve Replacement with a Balloon-Expandable Valve in Low-Risk Patients" (4,895).

Published TypeFieldAccessAuthorsCitations

Showing 50 of 60 papers. Every paper with more than 717 citations is listed.

Most cited papers, sortable by citations and release date
#	Paper
1	Toward defining the preclinical stages of Alzheimer's disease: Recommendations from the National Institute on Aging‐Alzheimer's Association workgroups on diagnostic guidelines for Alzheimer's disease Reisa Anne Sperling et al. · Alzheimer s & Dementia Open access	22 Apr 2011	7,286
2	Signet-Ring Cell Carcinoma of the Colon: A Case Report and Review of the Literature Peter Y. Park, Teresa A. Goldin, John C. S. Chang et al. · Case Reports in Oncology Open access	3 Nov 2015	5,277
3	Transcatheter Aortic-Valve Replacement with a Balloon-Expandable Valve in Low-Risk Patients Michael J. Mack et al. · New England Journal of Medicine Open access	16 Mar 2019	4,895
4	Inflammation and Alzheimer's disease Haruhiko Akiyama · Neurobiology of Aging Open access	Jun 2000	4,553
5	Social Capital, Networks, and Knowledge Transfer Andrew C. Inkpen, Eric W. K. Tsang · Academy of Management Review	2005	3,850
6	Genetic meta-analysis of diagnosed Alzheimer’s disease identifies new risk loci and implicates Aβ, tau, immunity and lipid processing Brian W. Kunkle et al. · Nature Genetics ReviewOpen access469 authors	28 Feb 2019	3,277
7	National Institute on Aging–Alzheimer's Association guidelines for the neuropathologic assessment of Alzheimer's disease Bradley T. Hyman, Creighton H. Phelps, Thomas G. Beach et al. · Alzheimer s & Dementia Open access	2012	3,246
8	National Institute on Aging–Alzheimer’s Association guidelines for the neuropathologic assessment of Alzheimer’s disease: a practical approach Thomas Jude Montine, Creighton H. Phelps, Thomas G. Beach et al. · Acta Neuropathologica Open access	19 Nov 2011	2,988
9	Mapping genomic loci implicates genes and synaptic biology in schizophrenia Vassily Vladimirovich Trubetskoy et al. · Nature Open access613 authors	8 Apr 2022	2,894
10	Revised criteria for diagnosis and staging of Alzheimer's disease: Alzheimer's Association Workgroup Clifford R. Jack, Jeffrey Scott Andrews, Thomas G. Beach et al. · Alzheimer s & Dementia Open access	27 Jun 2024	2,670
11	New insights into the genetic etiology of Alzheimer’s disease and related dementias Céline Bellenguez et al. · Nature Genetics Open access1,266 authors	Apr 2022	2,608
12	Long-term safety and activity of axicabtagene ciloleucel in refractory large B-cell lymphoma (ZUMA-1): a single-arm, multicentre, phase 1–2 trial Frederick Lundry Locke et al. · The Lancet Oncology Open access	2 Dec 2018	2,307
13	Correlation of Alzheimer Disease Neuropathologic Changes With Cognitive Status: A Review of the Literature Peter T. Nelson et al. · Journal of Neuropathology & Experimental Neurology Open access	6 Apr 2012	2,144
14	Analysis of shared heritability in common disorders of the brain Verneri Anttila et al. · Science Open access577 authors	21 Jun 2018	2,056
15	Common variants at MS4A4/MS4A6E, CD2AP, CD33 and EPHA1 are associated with late-onset Alzheimer's disease Adam Christian Naj et al. · Nature Genetics Open access155 authors	3 Apr 2011	2,024
16	Prevalence of Cerebral Amyloid Pathology in Persons Without Dementia Willemijn J. Jansen et al. · JAMA Open access129 authors	19 May 2015	1,662
17	Discriminative Accuracy of Plasma Phospho-tau217 for Alzheimer Disease vs Other Neurodegenerative Disorders Sebastian Palmqvist et al. · JAMA Open access	28 Jul 2020	1,657
18	Soluble Amyloid β Peptide Concentration as a Predictor of Synaptic Change in Alzheimer's Disease Lih‐Fen Lue, Yu‐Min Kuo, Alex E. Roher et al. · American Journal Of Pathology Open access	Sep 1999	1,541
19	Primary age-related tauopathy (PART): a common pathology associated with human aging John F. Crary et al. · Acta Neuropathologica Open access	27 Oct 2014	1,541
20	Service Research Priorities in a Rapidly Changing Context Amy L. Ostrom, Anitha Parasuraman, David E. Bowen et al. · Journal of Service Research	13 Apr 2015	1,467
21	PD-1 Blockade with Cemiplimab in Advanced Cutaneous Squamous-Cell Carcinoma Michael Robert Migden et al. · New England Journal of Medicine Open access	4 Jun 2018	1,430
22	Disease duration and the integrity of the nigrostriatal system in Parkinson’s disease Jeffrey H. Kordower, C. Warren Olanow, Hemraj B. Dodiya et al. · Brain Open access	23 Jul 2013	1,367
23	KNOWLEDGE, BARGAINING POWER, AND THE INSTABILITY OF INTERNATIONAL JOINT VENTURES Andrew C. Inkpen, Paul W. Beamish · Academy of Management Review	1997	1,362
24	APOE4 leads to blood–brain barrier dysfunction predicting cognitive decline Axel Montagne et al. · Nature Open access	29 Apr 2020	1,321
25	Plasma P-tau181 in Alzheimer’s disease: relationship to other biomarkers, differential diagnosis, neuropathology and longitudinal progression to Alzheimer’s dementia Shorena Janelidze, Niklas Mattsson, Sebastian Palmqvist et al. · Nature Medicine	Mar 2020	1,306
26	Upper-Airway Stimulation for Obstructive Sleep Apnea Patrick J. Strollo, Ryan J. Soose, Joachim Theodor Maurer et al. · New England Journal of Medicine Open access	8 Jan 2014	1,289
27	Early role of vascular dysregulation on late-onset Alzheimer’s disease based on multifactorial data-driven analysis Yasser Iturria‐Medina et al. · Nature Communications Open access316 authors	21 Jun 2016	1,244
28	Effectiveness of Atypical Antipsychotic Drugs in Patients with Alzheimer's Disease Lon S. S. Schneider, Pierre N. Tariot, Karen Dagerman et al. · New England Journal of Medicine Open access	11 Oct 2006	1,202
29	American Association of Clinical Endocrinologists and American College of Endocrinology Clinical Practice Guidelines for the Diagnosis and Treatment of Postmenopausal Osteoporosis — 2016--Executive Summary Pauline M. Camacho, Steven M. Petak, Neil Binkley et al. · Endocrine Practice	2016	1,147
30	Hold Your Horses: Impulsivity, Deep Brain Stimulation, and Medication in Parkinsonism Michael J. Frank, Johan Samanta, Ahmed A. Moustafa et al. · Science	25 Oct 2007	1,144
31	Rare coding variants in PLCG2, ABI3, and TREM2 implicate microglial-mediated innate immunity in Alzheimer's disease Rebecca C. Sims et al. · Nature Genetics Open access450 authors	17 Jul 2017	1,122
32	Accuracy of the Clinical Diagnosis of Alzheimer Disease at National Institute on Aging Alzheimer Disease Centers, 2005–2010 Thomas G. Beach, Sarah E. Monsell, Leslie E. Phillips et al. · Journal of Neuropathology & Experimental Neurology Open access	22 Mar 2012	1,122
33	Determinants of individual engagement in knowledge sharing Angel Julio Romero Cabrera, William C. Collins, Jesús F. Salgado · The International Journal of Human Resource Management	Feb 2006	1,117
34	Large-scale proteomic analysis of Alzheimer’s disease brain and cerebrospinal fluid reveals early changes in energy metabolism associated with microglia and astrocyte activation Erik C. B. Johnson et al. · Nature Medicine Open access	13 Apr 2020	1,099
35	Clinical trial of indomethacin in Alzheimer's disease Jospeh Rogers, L. Kirby, S. R. Hempelman et al. · Neurology	Aug 1993	1,002
36	Inflammation in Alzheimer Disease--A Brief Review of the Basic Science and Clinical Literature Tony Wyss‐Coray, Joseph M. Rogers · Cold Spring Harbor Perspectives in Medicine Open access	15 Nov 2011	974
37	Acetylation of Tau Inhibits Its Degradation and Contributes to Tauopathy Sang-Won Min, Seo-Hyun Cho, Yungui Zhou et al. · Neuron Open access	Sep 2010	951
38	Multi-organ distribution of phosphorylated α-synuclein histopathology in subjects with Lewy body disorders Thomas G. Beach, Charles H. Adler, Lucia I. Sue et al. · Acta Neuropathologica Open access	20 Mar 2010	920
39	The Corporate Objective Revisited Anant K. Sundaram, Andrew C. Inkpen · Organization Science	Jun 2004	901
40	Development of a Definition of Postacute Sequelae of SARS-CoV-2 Infection Tanayott Thaweethai et al. · JAMA Open access825 authors	25 May 2023	881
41	PGC-1 α, A Potential Therapeutic Target for Early Intervention in Parkinson’s Disease Bin Zheng et al. · Science Translational Medicine Open access	6 Oct 2010	872
42	Cerebral PET with florbetapir compared with neuropathology at autopsy for detection of neuritic amyloid-β plaques: a prospective cohort study Christopher M. Clark, Michael J. Pontecorvo, Thomas G. Beach et al. · The Lancet Neurology	27 Jun 2012	865
43	Components of CEO Transformational Leadership and Corporate Social Responsibility* David A. Waldman, Donald S. Siegel, Mansour Javidan · Journal of Management Studies	24 Aug 2006	854
44	Treatment for Brain Metastases: ASCO-SNO-ASTRO Guideline Michael A. Vogelbaum et al. · Journal of Clinical Oncology Open access	21 Dec 2021	844
45	Complement activation by beta-amyloid in Alzheimer disease. Jack T. Rogers, Neil R. Cooper, Scott D. Webster et al. · Proceedings of the National Academy of Sciences Open access	Nov 1992	820
46	Winning the Service Game Benjamin Schneider, David E. Bowen · Service science: research and innovations in the service economy Book chapter	2010	816
47	Standard-of-Care Axicabtagene Ciloleucel for Relapsed or Refractory Large B-Cell Lymphoma: Results From the US Lymphoma CAR T Consortium Loretta J. Nastoupil et al. · Journal of Clinical Oncology Open access	13 May 2020	812
48	Performance guarantees in communication networks Cheng‐Shang Chang · European Transactions on Telecommunications Open access	Jul 2001	806
49	Phosphorylated TDP‐43 in frontotemporal lobar degeneration and amyotrophic lateral sclerosis Masato Hasegawa, Tetsuaki Arai, Takashi Nonaka et al. · Annals of Neurology Open access	10 Jun 2008	801
50	Danger Zone Entrepreneurs: The Importance of Resilience and Self–Efficacy for Entrepreneurial Intentions Amanda Bullough, Maija Renko, Tamara Myatt · Entrepreneurship Theory and Practice	16 Jan 2013	791

Citations are OpenAlex's own counts, from its 2026-09-23 snapshot, so the ranking can differ from Google Scholar or Web of Science. A paper is listed for an institution when any of its authors gave it as an affiliation; retracted papers and papers whose citation count cannot be traced to citing works are left out, and a preprint and the article it became are shown once. Release dates are OpenAlex's: where a source gave only a month or a year, that is what is shown. How the lists are chosen.